• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

vault 成分 MVP、TEP1 和 vPARP 的表达谱及其与卵巢癌中其他多药耐药蛋白的相关性。

Expression profiles of vault components MVP, TEP1 and vPARP and their correlation to other multidrug resistance proteins in ovarian cancer.

机构信息

Department of Histology and Embryology, Poznan University of Medical Sciences, 60-781 Poznań, Poland.

出版信息

Int J Oncol. 2013 Aug;43(2):513-20. doi: 10.3892/ijo.2013.1975. Epub 2013 Jun 5.

DOI:10.3892/ijo.2013.1975
PMID:23739867
Abstract

Vaults are cytoplasmic ribonucleoprotein particles composed of three proteins (MVP, TEP1, vPARP) and vault‑associated RNAs (vRNAs). Although the cellular functions of vaults remain unclear, vaults are strongly linked to the development of multidrug resistance (MDR), the major obstacle to the efficient treatment of cancers. Available published data suggest that vaults and their components are frequently upregulated in broad variety of multidrug-resistant cancer cell lines and tumors of different histological origin. Here, we provide detailed analysis of vault protein expression in post-surgery ovarian cancer samples from patients that were not exposed to chemotherapy. Our analysis suggests that vault proteins are expressed in the ovaries of healthy individuals but their expression in cancer patients is changed. Specifically, MVP, TEP1 and vPARP mRNA levels are significantly decreased in cancer samples with tendency of lower expression in higher-grade tumors. The pattern of vault protein mRNA expression is strongly correlated with the expression of other MDR-associated proteins such as MDR1, MRP1 and BCRP. Surprisingly, the protein levels of MVP, TEP1 and vPARP are actually increased in the higher‑grade tumors suggesting existence of post-transcriptional regulation of vault component production.

摘要

穹窿是由三种蛋白质(MVP、TEP1、vPARP)和穹窿相关 RNA(vRNA)组成的细胞质核糖核蛋白颗粒。尽管穹窿的细胞功能仍不清楚,但穹窿与多药耐药(MDR)的发展密切相关,MDR 是有效治疗癌症的主要障碍。现有发表的数据表明,穹窿及其成分在广泛的多药耐药癌细胞系和不同组织来源的肿瘤中经常上调。在这里,我们对未接受化疗的手术后卵巢癌患者样本中的穹窿蛋白表达进行了详细分析。我们的分析表明,穹窿蛋白在健康个体的卵巢中表达,但在癌症患者中的表达发生了变化。具体而言,MVP、TEP1 和 vPARP 的 mRNA 水平在癌症样本中显著降低,且在高级别肿瘤中表达倾向更低。穹窿蛋白 mRNA 表达模式与其他多药耐药相关蛋白(如 MDR1、MRP1 和 BCRP)的表达强烈相关。令人惊讶的是,MVP、TEP1 和 vPARP 的蛋白水平实际上在高级别肿瘤中增加,表明穹窿成分产生存在转录后调控。

相似文献

1
Expression profiles of vault components MVP, TEP1 and vPARP and their correlation to other multidrug resistance proteins in ovarian cancer. vault 成分 MVP、TEP1 和 vPARP 的表达谱及其与卵巢癌中其他多药耐药蛋白的相关性。
Int J Oncol. 2013 Aug;43(2):513-20. doi: 10.3892/ijo.2013.1975. Epub 2013 Jun 5.
2
Analysis of MVP and VPARP promoters indicates a role for chromatin remodeling in the regulation of MVP.对MVP和VPARP启动子的分析表明染色质重塑在MVP调控中发挥作用。
Biochim Biophys Acta. 2004 Apr 16;1678(1):33-46. doi: 10.1016/j.bbaexp.2004.01.005.
3
Up-regulation of vaults may be necessary but not sufficient for multidrug resistance.穹窿体的上调可能是多药耐药所必需的,但并不充分。
Int J Cancer. 2001 Apr 15;92(2):195-202. doi: 10.1002/1097-0215(200102)9999:9999<::aid-ijc1168>3.0.co;2-7.
4
Cryoelectron microscopy imaging of recombinant and tissue derived vaults: localization of the MVP N termini and VPARP.重组及组织来源穹窿体的冷冻电子显微镜成像:主要穹窿体蛋白N端和穹窿体聚(ADP-核糖)聚合酶的定位
J Mol Biol. 2004 Nov 12;344(1):91-105. doi: 10.1016/j.jmb.2004.09.021.
5
The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.四种多药耐药蛋白在肝细胞癌多药耐药中的作用。
J Huazhong Univ Sci Technolog Med Sci. 2007 Apr;27(2):173-5. doi: 10.1007/s11596-007-0217-8.
6
Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications.多药耐药蛋白P-糖蛋白、多药耐药相关蛋白1、乳腺癌耐药蛋白及肺耐药相关蛋白在接受新辅助化疗的局部晚期膀胱癌中的表达:生物学及临床意义
J Urol. 2003 Oct;170(4 Pt 1):1383-7. doi: 10.1097/01.ju.0000074710.96154.c9.
7
vPARP Adjusts MVP Expression in Drug-resistant Cell Lines in Conjunction with MDR Proteins.vPARP与多药耐药蛋白共同调节耐药细胞系中MVP的表达。
Anticancer Res. 2017 Jun;37(6):3015-3023. doi: 10.21873/anticanres.11656.
8
Cellular functions of vaults and their involvement in multidrug resistance.穹窿体的细胞功能及其与多药耐药性的关系。
Curr Drug Targets. 2006 Aug;7(8):923-34. doi: 10.2174/138945006778019345.
9
Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).乳腺癌耐药蛋白(BCRP)在复发或难治性急性髓系白血病(AML)中的表达增加。
Leukemia. 2002 May;16(5):833-9. doi: 10.1038/sj.leu.2402496.
10
RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.乳腺癌中乳腺癌耐药蛋白、肺耐药相关蛋白、多药耐药相关蛋白1和2以及多药耐药基因1的RNA表达:与化疗反应的相关性
Clin Cancer Res. 2003 Feb;9(2):827-36.

引用本文的文献

1
Vault Particles in Cancer Progression, Multidrug Resistance, and Drug Delivery: Current Insights and Future Applications.核小体颗粒在癌症进展、多药耐药性及药物递送中的研究现状与未来应用
Int J Mol Sci. 2025 Feb 12;26(4):1562. doi: 10.3390/ijms26041562.
2
Human Vault RNAs: Exploring Their Potential Role in Cellular Metabolism.人类 Vault RNA:探索其在细胞代谢中的潜在作用。
Int J Mol Sci. 2024 Apr 6;25(7):4072. doi: 10.3390/ijms25074072.
3
Identification of a novel PARP4 gene promoter CpG locus associated with cisplatin chemoresistance.
鉴定与顺铂化疗耐药相关的新型 PARP4 基因启动子 CpG 位点。
BMB Rep. 2023 Jun;56(6):347-352. doi: 10.5483/BMBRep.2022-0202.
4
Small but Powerful: The Human Vault RNAs as Multifaceted Modulators of Pro-Survival Characteristics and Tumorigenesis.微小却强大:人类穹窿体RNA作为促生存特性和肿瘤发生的多面调节因子
Cancers (Basel). 2022 Jun 3;14(11):2787. doi: 10.3390/cancers14112787.
5
MVP Expression Facilitates Tumor Cell Proliferation and Migration Supporting the Metastasis of Colorectal Cancer Cells.MVP 表达促进肿瘤细胞增殖和迁移,支持结直肠癌细胞的转移。
Int J Mol Sci. 2021 Nov 9;22(22):12121. doi: 10.3390/ijms222212121.
6
Low Expression of SLC7A11 Confers Drug Resistance and Worse Survival in Ovarian Cancer Inhibition of Cell Autophagy as a Competing Endogenous RNA.SLC7A11低表达赋予卵巢癌耐药性并导致更差的生存结局 细胞自噬的抑制作为一种竞争性内源性RNA
Front Oncol. 2021 Nov 1;11:744940. doi: 10.3389/fonc.2021.744940. eCollection 2021.
7
Extracellular vesicles in inflammation: Focus on the microRNA cargo of EVs in modulation of liver diseases.细胞外囊泡在炎症中的作用:聚焦于 EVs 中 microRNA 货物在肝脏疾病调节中的作用。
J Leukoc Biol. 2022 Jan;111(1):75-92. doi: 10.1002/JLB.3MIR0321-156R. Epub 2021 Nov 10.
8
Tumor genomic, transcriptomic, and immune profiling characterizes differential response to first-line platinum chemotherapy in high grade serous ovarian cancer.肿瘤基因组、转录组和免疫特征分析揭示高级别浆液性卵巢癌一线铂类化疗反应的差异。
Cancer Med. 2021 May;10(9):3045-3058. doi: 10.1002/cam4.3831. Epub 2021 Apr 3.
9
The Vault Nanoparticle: A Gigantic Ribonucleoprotein Assembly Involved in Diverse Physiological and Pathological Phenomena and an Ideal Nanovector for Drug Delivery and Therapy.穹窿体纳米颗粒:一种参与多种生理和病理现象的巨大核糖核蛋白组装体,也是药物递送与治疗的理想纳米载体。
Cancers (Basel). 2021 Feb 9;13(4):707. doi: 10.3390/cancers13040707.
10
CircularRNA circPARP4 promotes glioblastoma progression through sponging miR-125a-5p and regulating FUT4.环状RNA circPARP4通过吸附miR-125a-5p和调控FUT4促进胶质母细胞瘤进展。
Am J Cancer Res. 2021 Jan 1;11(1):138-156. eCollection 2021.